189 related articles for article (PubMed ID: 19451302)
1. In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains.
LaPlante KL; Mermel LA
Antimicrob Agents Chemother; 2009 Jul; 53(7):3166-9. PubMed ID: 19451302
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of telavancin studied in an in vitro pharmacokinetic model of infection.
MacGowan AP; Noel AR; Tomaselli S; Elliott HC; Bowker KE
Antimicrob Agents Chemother; 2011 Feb; 55(2):867-73. PubMed ID: 21078943
[TBL] [Abstract][Full Text] [Related]
3. Telavancin shows superior activity to vancomycin with multidrug-resistant Staphylococcus aureus in a range of in vitro biofilm models.
Smith K; Gemmell CG; Lang S
Eur J Clin Microbiol Infect Dis; 2013 Oct; 32(10):1327-32. PubMed ID: 23624635
[TBL] [Abstract][Full Text] [Related]
4. Effects of demethylfruticuline A and fruticuline A from Salvia corrugata Vahl. on biofilm production in vitro by multiresistant strains of Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.
Schito AM; Piatti G; Stauder M; Bisio A; Giacomelli E; Romussi G; Pruzzo C
Int J Antimicrob Agents; 2011 Feb; 37(2):129-34. PubMed ID: 21163629
[TBL] [Abstract][Full Text] [Related]
5. Telavancin: in vitro activity against staphylococci in a biofilm model.
Gander S; Kinnaird A; Finch R
J Antimicrob Chemother; 2005 Aug; 56(2):337-43. PubMed ID: 15972312
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
Mendes RE; Moet GJ; Janechek MJ; Jones RN
Antimicrob Agents Chemother; 2010 Jun; 54(6):2704-6. PubMed ID: 20385851
[TBL] [Abstract][Full Text] [Related]
7. Synthetic 3-arylideneflavanones as inhibitors of the initial stages of biofilm formation by Staphylococcus aureus and Enterococcus faecalis.
Budzyńska A; Rózalski M; Karolczak W; Wieckowska-Szakiel M; Sadowska B; Rózalska B
Z Naturforsch C J Biosci; 2011; 66(3-4):104-14. PubMed ID: 21630583
[TBL] [Abstract][Full Text] [Related]
8. Action of linezolid or vancomycin on biofilms in ventriculoperitoneal shunts in vitro.
Bayston R; Ullas G; Ashraf W
Antimicrob Agents Chemother; 2012 Jun; 56(6):2842-5. PubMed ID: 22430965
[TBL] [Abstract][Full Text] [Related]
9. Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
Draghi DC; Benton BM; Krause KM; Thornsberry C; Pillar C; Sahm DF
Antimicrob Agents Chemother; 2008 Jul; 52(7):2383-8. PubMed ID: 18443115
[TBL] [Abstract][Full Text] [Related]
10. Worldwide appraisal and update (2010) of telavancin activity tested against a collection of Gram-positive clinical pathogens from five continents.
Mendes RE; Sader HS; Farrell DJ; Jones RN
Antimicrob Agents Chemother; 2012 Jul; 56(7):3999-4004. PubMed ID: 22508304
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.
Tuazon CU; Miller H
Antimicrob Agents Chemother; 1984 Apr; 25(4):411-2. PubMed ID: 6233934
[TBL] [Abstract][Full Text] [Related]
12. Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.
Kosowska-Shick K; Clark C; Pankuch GA; McGhee P; Dewasse B; Beachel L; Appelbaum PC
Antimicrob Agents Chemother; 2009 Oct; 53(10):4217-24. PubMed ID: 19620338
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
Kotulová D; Slobodníková L
Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry as a tool to determine the effects of cell wall-active antibiotics on vancomycin-susceptible and -resistant Enterococcus faecalis strains.
Chau F; Lefort A; Benadda S; Dubée V; Fantin B
Antimicrob Agents Chemother; 2011 Jan; 55(1):395-8. PubMed ID: 20956587
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of the activities of telavancin, cefazolin, and vancomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus in peritoneal dialysate.
Clouse FL; Hovde LB; Rotschafer JC
Antimicrob Agents Chemother; 2007 Dec; 51(12):4521-4. PubMed ID: 17908947
[TBL] [Abstract][Full Text] [Related]
16. Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.
Opperman TJ; Kwasny SM; Williams JD; Khan AR; Peet NP; Moir DT; Bowlin TL
Antimicrob Agents Chemother; 2009 Oct; 53(10):4357-67. PubMed ID: 19651903
[TBL] [Abstract][Full Text] [Related]
17. Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Leonard SN; Vidaillac C; Rybak MJ
Antimicrob Agents Chemother; 2009 Jul; 53(7):2928-33. PubMed ID: 19414568
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
Karlowsky JA; Adam HJ; Poutanen SM; Hoban DJ; Zhanel GG;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
[TBL] [Abstract][Full Text] [Related]
19. Application of a feasible method for determination of biofilm antimicrobial susceptibility in staphylococci.
Antunes AL; Trentin DS; Bonfanti JW; Pinto CC; Perez LR; Macedo AJ; Barth AL
APMIS; 2010 Nov; 118(11):873-7. PubMed ID: 20955460
[TBL] [Abstract][Full Text] [Related]
20. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
Weigel LM; Donlan RM; Shin DH; Jensen B; Clark NC; McDougal LK; Zhu W; Musser KA; Thompson J; Kohlerschmidt D; Dumas N; Limberger RJ; Patel JB
Antimicrob Agents Chemother; 2007 Jan; 51(1):231-8. PubMed ID: 17074796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
